BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34403748)

  • 1. Automated blood sampling in canine telemetry model: Enhanced assessment of immune liabilities.
    Koshman YE; Lai-Zhang J; Wilsey AS; Bird BM; Sadilek S; Weisbecker DA; Ebert PA; Polakowski JS; Mittelstadt SW; Foley CM; LeRoy BE
    J Pharmacol Toxicol Methods; 2021; 112():107115. PubMed ID: 34403748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins.
    Koshman YE; Wilsey AS; Bird BM; Sadilek S; Weisbecker DA; Ebert PA; Polakowski JS; Gintant GA; Mittelstadt SW; Foley CM
    J Pharmacol Toxicol Methods; 2021; 111():107109. PubMed ID: 34416395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated blood sampling in canine telemetry studies: Enabling enhanced assessments of cardiovascular liabilities and safety margins.
    Koshman YE; Wilsey AS; Bird BM; Sadilek S; Weisbecker DA; Ebert PA; Polakowski JS; Gintant GA; Mittelstadt SW; Foley CM
    J Pharmacol Toxicol Methods; 2021; 109():107066. PubMed ID: 33838254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated Blood Sampling in a Canine Telemetry Cardiovascular Model.
    Wilsey AS; Koshman YE; Weisbecker DA; Bird BM; Mirakhur KK; Sadilek S; Ebert PA; Polakowski JS; Foley CM; Medina CL; Mittelstadt SW
    Comp Med; 2021 Apr; 71(2):133-140. PubMed ID: 33814031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new telemetry-based system for assessing cardiovascular function in group-housed large animals. Taking the 3Rs to a new level with the evaluation of remote measurement via cloud data transmission.
    Markert M; Trautmann T; Krause F; Cioaga M; Mouriot S; Wetzel M; Guth BD
    J Pharmacol Toxicol Methods; 2018; 93():90-97. PubMed ID: 29597013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants.
    Chui RW; Fosdick A; Conner R; Jiang J; Bruenner BA; Vargas HM
    J Pharmacol Toxicol Methods; 2009; 60(1):58-68. PubMed ID: 19426820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of freely-moving telemetry Chinese Miniature Experiment Pigs (CMEPs) to beagle dogs in cardiovascular safety pharmacology studies.
    Yuan H; Zhao J; Guo J; Wu R; He L; Cui Y; Feng M; Zhang T; Hou M; Guo Q; Zhang L; Jia L; Huang C; Ye L; Peng S
    J Pharmacol Toxicol Methods; 2014; 70(1):19-28. PubMed ID: 24721420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development.
    Caruso A; Frances N; Meille C; Greiter-Wilke A; Hillebrecht A; Lavé T
    J Pharmacol Toxicol Methods; 2014; 70(1):73-85. PubMed ID: 24879942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and utility of the PhysioTel™ Digital M11 telemetry implant for cardiovascular data evaluation in cynomolgus monkeys and Beagle dogs.
    Cordes JS; Heyen JR; Volberg ML; Poy N; Kreuser S; Shoieb AM; Steidl-Nichols J
    J Pharmacol Toxicol Methods; 2016; 79():72-9. PubMed ID: 26844408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the utility of LVdP/dt
    Pugsley MK; Guth B; Chiang AY; Doyle JM; Engwall M; Guillon JM; Hoffmann PK; Koerner JE; Mittelstadt SW; Pierson JB; Rossman EI; Sarazan DR; Parish ST
    J Pharmacol Toxicol Methods; 2017; 85():1-21. PubMed ID: 28065821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid attenuates the expression of pro-inflammatory cytokines lipopolysaccharide-treated canine peripheral blood mononuclear cells (in vitro) and in a canine endotoxemia model (in vivo).
    Song R; Yu D; Yoon J; Park J
    Vet Immunol Immunopathol; 2015 Aug; 166(3-4):132-7. PubMed ID: 26160312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of the inflammatory response during experimental Babesia rossi infection of beagle dogs.
    Atkinson BK; Thompson P; Van Zyl E; Goddard A; Rautenbach Y; Schoeman JP; Mukorera V; Leisewitz A
    Vet Parasitol; 2022 Jun; 306():109717. PubMed ID: 35606218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs.
    Calvalido J; Wood GA; Mutsaers AJ; Wood D; Sears W; Woods JP
    Vet Immunol Immunopathol; 2016 Dec; 182():106-114. PubMed ID: 27863540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of housing conditions on baseline cardiovascular parameters and the sensitivity to detect changes in contractility in telemetry-implanted dogs.
    Sadekova N; Boudreau G; Jalbert B; Norton K
    J Pharmacol Toxicol Methods; 2016; 81():60-74. PubMed ID: 27163176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an investigative safety pharmacology model to assess comprehensive cardiac function and structure in chronically instrumented conscious beagle dogs.
    Regan CP; Stump GL; Detwiler TJ; Chen L; Regan HK; Gilberto DB; DeGeorge JJ; Sannajust FJ
    J Pharmacol Toxicol Methods; 2016; 81():107-14. PubMed ID: 27166580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cardiovascular changes in dogs administered three positive controls using jacketed external telemetry-blood pressure (JET-BP).
    Kremer JJ; Bills AJ; Hanke NJ; Chen H; Meier WA; Osinski MA; Foley CM
    J Pharmacol Toxicol Methods; 2015; 75():27-37. PubMed ID: 26001324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous solid tip ECG lead placement in telemetry implanted dogs: Part 2: High quality telemetry signals yield high sensitivity to drug-induced changes.
    Mitchell AZ; Bills AJ; Wittwer GT; Foley CM; Kremer JJ; Chen H; Osinski MA
    J Pharmacol Toxicol Methods; 2013; 68(1):62-73. PubMed ID: 23639348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrative pharmacokinetic-cardiovascular physiology modelling approach based on in vivo dog studies including five reference compounds.
    Wallman M; Borghardt JM; Martel E; Pairet N; Markert M; Jirstrand M
    J Pharmacol Toxicol Methods; 2022; 115():107171. PubMed ID: 35398273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A canine model used to simultaneously assess potential neurobehavioural and cardiovascular effects of candidate drugs.
    Tontodonati M; Fasdelli N; Moscardo E; Giarola A; Dorigatti R
    J Pharmacol Toxicol Methods; 2007; 56(2):265-75. PubMed ID: 17587603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortium.
    Guth BD; Chiang AY; Doyle J; Engwall MJ; Guillon JM; Hoffmann P; Koerner J; Mittelstadt S; Ottinger S; Pierson JB; Pugsley MK; Rossman EI; Walisser J; Sarazan RD
    J Pharmacol Toxicol Methods; 2015; 75():70-90. PubMed ID: 25843226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.